Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Series A Preferred Stock Preferred Stock	Common Stock	Additional Paid-In-Capital	Dividends in Excess of Earnings	Total
Balances at beginning of period at Dec. 31, 2022	$ 14,009	$ 28	$ 2,065,248	$ (117,392)	$ 1,961,893
Balances at beginning of period (in shares) at Dec. 31, 2022		27,972,830
Net Income (Loss)				41,092	41,092
Issuance of unvested restricted stock, net of forfeitures			(568)		(568)
Issuance of unvested restricted stock, net of forfeitures (in shares)		29,969
Exchange of Exchangeable Senior Notes			1,964		1,964
Exchange of Exchangeable Senior Notes (in shares)		32,200
Preferred stock dividend				(338)	(338)
Common stock dividend				(50,725)	(50,725)
Stock-based compensation			4,829		4,829
Balances at end of period at Mar. 31, 2023	14,009	$ 28	2,071,473	(127,363)	1,958,147
Balances at end of period (in shares) at Mar. 31, 2023		28,034,999
Balances at beginning of period at Dec. 31, 2023	14,009	$ 28	2,095,789	(156,854)	1,952,972
Balances at beginning of period (in shares) at Dec. 31, 2023		28,140,891
Net Income (Loss)				39,428	39,428
Issuance of unvested restricted stock, net of forfeitures			(750)		(750)
Issuance of unvested restricted stock, net of forfeitures (in shares)		36,124
Exchange of Exchangeable Senior Notes (in shares)		28,408
Net proceeds from sale of common stock			11,757		11,757
Net proceeds from sale of common stock (in shares)		123,224
Preferred stock dividend				(338)	(338)
Common stock dividend				(51,957)	(51,957)
Stock-based compensation			4,315		4,315
Balances at end of period at Mar. 31, 2024	$ 14,009	$ 28	$ 2,111,111	$ (169,721)	$ 1,955,427
Balances at end of period (in shares) at Mar. 31, 2024		28,328,647